{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:57:00Z","timestamp":1773093420042,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T00:00:00Z","timestamp":1345507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: COPD, a leading cause of mortality is currently assessed by spirometry (forced expiratory volume in 1 second, FEV1). However FEV1 does not correlate with patient mortality. ECLIPSE (Evaluation of Chronic obstructive pulmonary disease to Longitudinally Identify Predictive Surrogate Endpoints) aims to identify biomarkers that correlate with clinically relevant COPD subtypes, and to assess how these may predict disease progression. New methods were developed and validated to evaluate small molecules as potential diagnostic tools in patients with COPD, COPD related cachexia and cancer related cachexia. Methods and findings: quantitative LC-MS\/MS was developed to measure 34 amino acids and dipeptides for stratification of patient groups. Subsets of the ECLIPSE patients were used to assess biomarkers of lung obstruction; GOLD IV (n = 30) versus control (n = 30); emphysema (n = 38) versus airways disease (n = 21) and cachexia (n = 30) versus normal body mass index (n = 30). Serum from cachexic (n = 7) and non-cachexic (n = 5) pancreatic cancer patients were included as controls. Targeted LC-MS\/MS distinguished GOLD IV patients from controls, patients with and without emphysema and patients with and without cachexia. Glutamine, aspartate and arginine were significantly increased (p &amp;lt; 0.05; FDR adjustment \u03b1 &amp;lt; 0.1) in cachexia, emphysema and GOLD IV patients and aminoadipate was decreased. Several amino acid concentrations were significantly altered in patients with COPD but not patients with pancreatic cancer (serine, sarcosine, tryptophan, BCAAs and 3-methylhistdine). Increased \u03b3-aminobutyrate (GABA, p &amp;lt; 0.01) levels were specific to cachexia in patients with pancreatic cancer. \u03b2-aminoisobutyrate, 1-methylhistidine and asparagine (p &amp;lt; 0.05) were common across the patients with cachexia from both the COPD and pancreatic cancer cohorts. Conclusion: these results demonstrate that a metabolomic fingerprint has potential to stratify patients for the treatment of COPD and may provide a means of assessing response to therapy. GOLD IV patients were distinguished from smoker control subjects, patients with emphysema were distinguished from those without emphysema and COPD patients displaying cachexia were distinguished from those not displaying cachexia. General markers of cachexia were discovered reflecting both COPD- and pancreatic cancer-related cachexia (increased glutamine, aspartate, arginine, and asparagine and decreased aminoadipate, \u03b2-aminoisobutyrate and 1-methylhistidine). Metabolomic biomarkers, particularly altered levels of GABA, could be exploited as a way of monitoring treatment efficacy and tumour recurrence for patients with pancreatic cancer experiencing cachexia.<\/jats:p>\n                  <jats:p\/>","DOI":"10.1039\/c2mb25194a","type":"journal-article","created":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T06:33:14Z","timestamp":1345530794000},"page":"3125-3133","source":"Crossref","is-referenced-by-count":107,"title":["Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD"],"prefix":"10.1093","volume":"8","author":[{"given":"Baljit K","family":"Ubhi","sequence":"first","affiliation":[{"name":"Department of Biochemistry and the Cambridge Systems Biology Centre, University of Cambridge a , UK \u00a0 bs405@cam.ac.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kian Kai","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Bioprocess Engineering, Universiti Teknologi Malaysia b , Johor Bahru, Malaysia"},{"name":"Department of Biochemistry and the Cambridge Systems Biology Centre, University of Cambridge a , UK \u00a0 bs405@cam.ac.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyang","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Physics, Xiamen University c , Xiamen, China"},{"name":"Department of Biochemistry and the Cambridge Systems Biology Centre, University of Cambridge a , UK \u00a0 bs405@cam.ac.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Janowitz","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cancer Research UK, Cambridge Research Institute d , Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Jodrell","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cancer Research UK, Cambridge Research Institute d , Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Tal-Singer","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, King of Prussia e , PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"MacNee","sequence":"additional","affiliation":[{"name":"Centre for Inflammation Research, Queen\u2019s Medical Research Institute f , Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Lomas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge, Cambridge Institute for Medical Research g , Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H","family":"Riley","sequence":"additional","affiliation":[{"name":"Respiratory MDC, GlaxoSmithKline h , Stevenage, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian L","family":"Griffin","sequence":"additional","affiliation":[{"name":"MRC Human Nutrition Research, Elsie Widdowson Laboratory i , Cambridge, UK"},{"name":"Department of Biochemistry and the Cambridge Systems Biology Centre, University of Cambridge a , UK \u00a0 bs405@cam.ac.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan C","family":"Connor","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and the Cambridge Systems Biology Centre, University of Cambridge a , UK \u00a0 bs405@cam.ac.uk"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,8,21]]},"reference":[{"key":"2026012913092195300_cit1"},{"key":"2026012913092195300_cit2","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1164\/ajrccm.164.9.2104035","article-title":"Peripheral Muscle Wasting in COPD. Clinical Relevance and Mechanisms","volume":"164","author":"Debigare","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026012913092195300_cit3"},{"key":"2026012913092195300_cit4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The Body Mass Index Airflow Obstruction, Dyspnea and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease","volume":"350","author":"Celli","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"2026012913092195300_cit5","first-page":"1","article-title":"Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease","volume":"9","author":"Jagoe","year":"2003","journal-title":"Eur. Respir. J."},{"key":"2026012913092195300_cit6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1471-2407-9-255","article-title":"Pancreatic Cancer Related Cachexia: Influence on Metabolism and Correlation to Weight Loss and Pulmonary Function","volume":"9","author":"Bachmann","year":"2009","journal-title":"BMC Cancer"},{"key":"2026012913092195300_cit7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"\u201cMetabonomics\u201d: Understanding the Metabolic Responses of Living Systems to Pathophysiological Stimuli via Multivariate Statistical Analysis of Biological NMR spectroscopic data.","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"issue":"5","key":"2026012913092195300_cit8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cbpa.2003.08.008","article-title":"Metabonomics: NMR Spectroscopy and Pattern Recognition Analysis of Body Fluids and Tissues for Characterisation of Xenobiotic Toxicity and Disease Diagnosis","volume":"7","author":"Griffin","year":"2003","journal-title":"Curr. Opin. Chem. Biol."},{"key":"2026012913092195300_cit9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0192623307310947","article-title":"Metabolic Profiling as a Tool for Understanding Mechanisms of Toxicity","volume":"36","author":"Clarke","year":"2008","journal-title":"Toxicol. Pathol."},{"key":"2026012913092195300_cit10","first-page":"376","article-title":"The Nutritional Status of Patients with Chronic Obstructive Pulmonary Disease","volume":"124","author":"Hunter","year":"1981","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026012913092195300_cit11","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/ajrccm\/143.6.1248","article-title":"Energy Balance in Patients with Chronic Obstructive Pulmonary Disease.","volume":"143","author":"Schols","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026012913092195300_cit12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/cs0830109","article-title":"Comparisons between Basal Metabolic Rate and Diet-Induced Thermogenesis in Different Types of Chronic Obstructive Pulmonary Disease","volume":"83","author":"Green","year":"1992","journal-title":"Clin. Sci."},{"key":"2026012913092195300_cit13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1164\/ajrccm.158.3.9708097","article-title":"Plasma and Muscle Amino-Acid Levels in Relation to Resting Energy Expenditure and Inflammation in Stable COPD","volume":"158","author":"Pouw","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2026012913092195300_cit14","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ajcn\/72.6.1480","article-title":"Factors Contributing to Alterations in Skeletal Muscle and Plasma Amino Acid Profiles in Patients with Chronic Obstructive Pulmonary Disease","volume":"72","author":"Engelen","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"2026012913092195300_cit15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/cs0750415","article-title":"Muscle Wasting in Emphysema","volume":"75","author":"Morrison","year":"1988","journal-title":"Clin. Sci."},{"key":"2026012913092195300_cit16","first-page":"546","article-title":"Plasma Amino Acid Levels in Patients with Chronic Obstructive Pulmonary Disease","volume":"48","author":"Schols","year":"1993","journal-title":"Monaldi Archives for Chest Disease."},{"key":"2026012913092195300_cit17","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1164\/ajrccm\/141.4_Pt_1.902","article-title":"The nutritional status in advanced emphysema associated with chronic bronchitis. A study of amino acid and catecholamine levels","volume":"141","author":"Hofford","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"2026012913092195300_cit18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1183\/09031936.00111707","article-title":"Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE)","volume":"31","author":"Vestbo","year":"2008","journal-title":"Eur. Respir. J."},{"key":"2026012913092195300_cit19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1465-9921-11-122","article-title":"Characterisation of COPD Heterogeneity in the ECLIPSE Cohort","volume":"11","author":"Agusti","year":"2010","journal-title":"Respir. Res."},{"key":"2026012913092195300_cit20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.aca.2005.02.042","article-title":"Analysis of Variance-Principal Component Analysis: A Soft Tool for Proteomic Discovery","volume":"544","author":"Harrington","year":"2005","journal-title":"Anal. Chim. Acta"},{"issue":"2","key":"2026012913092195300_cit21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0899-9007(00)00509-8","article-title":"Plasma Levels of Amino Acids and Hypermetabolism in Patients with Chronic Obstructive Pulmonary Disease","volume":"17","author":"Yoneda","year":"2008","journal-title":"Nutrition"},{"issue":"3","key":"2026012913092195300_cit22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/dmr.5610050303","article-title":"Effects of Branched-Chain Amino Acids on Protein Turnover","volume":"5","author":"May","year":"1989","journal-title":"Diabetes\/Metab. Rev."},{"issue":"1","key":"2026012913092195300_cit23","doi-asserted-by":"crossref","first-page":"319S","DOI":"10.1093\/jn\/136.1.319S","article-title":"Branched Chain Amino Acids: Metabolism, Physiological Function and Application","volume":"136","author":"Layman","year":"2006","journal-title":"J. Nutr."},{"key":"2026012913092195300_cit24","doi-asserted-by":"crossref","first-page":"333S","DOI":"10.1093\/jn\/136.1.333S","article-title":"Symposium on Branched Chain Amino Acids: Conference Summary","volume":"136","author":"Cynober","year":"2006","journal-title":"J. Nutr."},{"key":"2026012913092195300_cit25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ajcn\/83.4.829","article-title":"Greater Whole-Body Myofibrillar Protein Breakdown in Cachetic patients with Chronic Obstructive Pulmonary Disease","volume":"83","author":"Rutten","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"2026012913092195300_cit26","doi-asserted-by":"crossref","first-page":"9704","DOI":"10.1158\/0008-5472.CAN-07-2099","article-title":"Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor \u03c0 subunit","volume":"67","author":"Takehara","year":"2007","journal-title":"Cancer Res."},{"issue":"7","key":"2026012913092195300_cit27","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.cell.2009.04.022","article-title":"Loss of GABAergic Signaling by AgRP Neurons to the Parabrachial Nucleus Leads to Starvation","volume":"137","author":"Wu","year":"2009","journal-title":"Cell"}],"container-title":["Molecular BioSystems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/8\/12\/3125\/66155623\/c2mb25194a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/8\/12\/3125\/66155623\/c2mb25194a.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T18:13:33Z","timestamp":1769710413000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article\/8\/12\/3125\/8349811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,21]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,8,21]]}},"URL":"https:\/\/doi.org\/10.1039\/c2mb25194a","relation":{},"ISSN":["1742-2051","1742-206X"],"issn-type":[{"value":"1742-2051","type":"electronic"},{"value":"1742-206X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,12,1]]},"published":{"date-parts":[[2012,8,21]]}}}